Picture of Sanjivani Paranteral logo

531569 Sanjivani Paranteral Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m+5.94%
3m+26.49%
6m+2.85%
1yr+126.67%
Volume Change (%)
10d/3m-17.61%
Price vs... (%)
52w High-2.49%
50d MA+10.85%
200d MA+31.21%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital24.67%
Return on Equity49.66%
Operating Margin13.43%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Sanjivani Paranteral EPS forecast chart

Profile Summary

Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, anti-spasmodic, multivitamin, nutrition, iron, NSAID and analgesic, analgesic anti spasmodic, analgesic, and NSAID. Its antibiotic includes Netilmicin Sulphate, Amikacin Sulphate, and Gentamycin Sulphate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic includes Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamin include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, Diazepam, and Dobutamine Hydrochloride. Its Iron includes iron Sucrose. Its analgesic includes Metamizole.

Directors

    Last Annual
    March 31st, 2024
    Last Interim
    March 31st, 2024
    Incorporated
    October 5th, 1994
    Public Since
    January 22nd, 1996
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    in flag iconBombay Stock Exchange
    Shares in Issue
    11,684,300

    531569 Share Price Performance

    Upcoming Events for 531569

    Q1 2025 Sanjivani Paranteral Ltd Earnings Release

    Q2 2025 Sanjivani Paranteral Ltd Earnings Release

    Similar to 531569

    Picture of Achyut Healthcare logo

    Achyut Healthcare

    in flag iconBombay Stock Exchange

    Picture of Adline Chem Lab logo

    Adline Chem Lab

    in flag iconBombay Stock Exchange

    Picture of MPS Pharmaa logo

    MPS Pharmaa

    in flag iconBombay Stock Exchange

    Picture of Albert David logo

    Albert David

    in flag iconBombay Stock Exchange

    Picture of Ambalal Sarabhai Enterprises logo

    Ambalal Sarabhai Enterprises

    in flag iconBombay Stock Exchange

    FAQ